Today (17 July), SBRI Healthcare have announced two funding competitions relevant to BIVDA members: one on AMR and one on women’s health.
Both competitions close on 28 August 2024 at 1pm.
AMR Competition:
The competition is open to any innovation (e.g., medical device, in-vitro diagnostic, digital health solutions and AI solutions, behavioural interventions, and service improvements) that meets the entry criteria and the challenges described in the Challenge brief.
At early stage, the SBRI Healthcare programme offers a two-phased development approach;
Phase 1 contracts for technical and commercial feasibility testing are valued at up to £100,000 (NET) and last for six months. If successful, Phase 1 projects are entitled to apply for Phase 2 contracts for prototype development and early clinical evidence which are usually worth up to £800,000 (NET) over 12 months, subject to budget availability.
A BRIEFING WEBINAR will be held on Thurs 25 July 10am-12pm. Register on Eventbrite here.
For more details about the competition including how to apply, click here.
Women’s Health Competition:
The competition is open to any innovation (e.g., medical device, in-vitro diagnostic, digital health solutions and AI solutions, behavioural interventions, and service improvements) that meets the entry criteria and the challenges described in the Challenge brief.
At early stage, the SBRI Healthcare programme offers a two-phased development approach;
Phase 1 contracts for technical and commercial feasibility testing are valued at up to £100,000 (NET) and last for six months. If successful, Phase 1 projects are entitled to apply for Phase 2 contracts for prototype development and early clinical evidence which are usually worth up to £800,000 (NET) over 12 months, subject to budget availability.
For more details about the competition including how to apply, click here.
